NCT05473338

Brief Summary

The purpose of this study is to investigate, for the first time, whether gut bacteria composition and function of patients with CRPS differ from those of healthy adults. Samples of stool, urine and blood will be collected from patients with CRPS and from healthy adults. The type and function of bacteria of CRPS patients will be analyzed and compared to those of healthy adults to test if potential differences could explain the mechanism/s involved with the development of CRPS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

April 14, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 25, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2022

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

October 18, 2022

Status Verified

October 1, 2022

Enrollment Period

6 months

First QC Date

April 12, 2022

Last Update Submit

October 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gut microbiome composition

    Assessment of genomic composition of the gut bacteria by differential abundance analysis will be performed using 16S rRNA (Genome-Quebec)

    1 day

  • Presence of stool microbiota-related metabolites affecting host physiology

    Concentration of bile acids and short-chain-fatty-acids through Metabolomics analysis (Metabolon, USA).

    1 day

Secondary Outcomes (4)

  • Short-form health-questionnaire (SF12) score

    1 day

  • Brief Pain Inventory (BPI) score

    1 day

  • Patient Health Questionnaire (PHQ-9) score

    1 day

  • Pittsburg Sleep Quality Index (PSQI) scores

    1 day

Study Arms (2)

CRPS (Complex Regional Pain Syndrome)

Participants with CRPS (Complex Regional Pain Syndrome))

Diagnostic Test: Stool and blood samplesOther: Physical examinationOther: Questionnaires

Healthy

Healthy individuals

Diagnostic Test: Stool and blood samplesOther: Questionnaires

Interventions

fecal microbiome and metabolomics, as well as metabolites in plasma

CRPS (Complex Regional Pain Syndrome)Healthy

physical examination performed by a physician to confirm CRPS diagnosis and assess patient's eligibility to participate in the study. The exam will include skin temperature measured using a laser/infrared skin thermometry.

CRPS (Complex Regional Pain Syndrome)

Questionnaires measuring pain level, sleep, mood and diet parameters.

CRPS (Complex Regional Pain Syndrome)Healthy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult women and men with CRPS and healthy volunteers.

You may qualify if:

  • Women and men over the age of 18, diagnosed with CRPS of the upper or lower limb according to the Clinical Budapest Criteria, with a duration of 6 months and over (for the 1st study group).
  • Healthy women and men over the age of 18, who share a household with a CRPS patients participating in the study (for the 1st control group).
  • Healthy women and men over the age of 18 (for the 2nd control group).
  • Be able to read and write in either French, English or Hebrew.

You may not qualify if:

  • Any major illness (eg. malignancy, active inflammatory disease, metabolic disease, etc.)
  • Pregnancy
  • Chronic pain conditions (other than CRPS in the patients group)
  • Acute illness of any type in the preceding 1 month
  • Use of systemic antibiotics in the preceding 1 month
  • Change in any other regularly taken medications in the past 1 month
  • Substantial dietary / gastrointestinal alterations in the past 1 month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alan Edwards Pain Management Unit - Montreal General Hospital

Montreal, Quebec, H3G 1A4, Canada

Location

Related Publications (4)

  • Birklein F, Ajit SK, Goebel A, Perez RSGM, Sommer C. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018 May;14(5):272-284. doi: 10.1038/nrneurol.2018.20. Epub 2018 Mar 16.

    PMID: 29545626BACKGROUND
  • Birklein F, O'Neill D, Schlereth T. Complex regional pain syndrome: An optimistic perspective. Neurology. 2015 Jan 6;84(1):89-96. doi: 10.1212/WNL.0000000000001095. Epub 2014 Dec 3.

    PMID: 25471395BACKGROUND
  • Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007 May-Jun;8(4):326-31. doi: 10.1111/j.1526-4637.2006.00169.x.

    PMID: 17610454BACKGROUND
  • Minerbi A, Gonzalez E, Brereton NJB, Anjarkouchian A, Dewar K, Fitzcharles MA, Chevalier S, Shir Y. Altered microbiome composition in individuals with fibromyalgia. Pain. 2019 Nov;160(11):2589-2602. doi: 10.1097/j.pain.0000000000001640.

    PMID: 31219947BACKGROUND

MeSH Terms

Interventions

DefecationBlood Specimen CollectionRestraint, PhysicalSurveys and Questionnaires

Intervention Hierarchy (Ancestors)

Digestive System Physiological PhenomenaDigestive System and Oral Physiological PhenomenaSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesBehavior ControlTherapeuticsImmobilizationData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Yoram Shir, MD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, the Alan Edwards Pain Management Unit

Study Record Dates

First Submitted

April 12, 2022

First Posted

July 25, 2022

Study Start

April 14, 2022

Primary Completion

October 14, 2022

Study Completion

June 30, 2024

Last Updated

October 18, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations